Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.
The global Circulating Tumor Cell (CTC) Diagnostics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Circulating Tumor Cell (CTC) Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Circulating Tumor Cell (CTC) Diagnostics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
ApoCell, Inc. (US)
Biocep Ltd. (Israel)
Biocept, Inc. (US)
Biofluidica Microtechnologies LLC (US)
Celltraffix Inc. (US)
Clearbridge Biomedics (Singapore)
Creatv Microtech, Inc. (US)
Cynvenio Biosystems, Inc. (US)
Epic Biosciences Inc. (US)
Fluxion Biosciences, Inc. (US)
Ikonisys, Inc. (US)
IVDiagnostics, Inc. (US)
Janssen Diagnostics LLC (US)
QIAGEN Hannover GmbH (Germany)
RARECELLS SAS (Italy)
ScreenCell (France)
STEMCELL Technologies, Inc. (Canada)
Segment by Regions
North America
Europe
China
Japan
Segment by Type
CTC Enrichment
CTC Detection
Segment by Application
Hospitals and clinics
Pharmaceuticals and biotechnology companies
Academic research institutes
CROs
Table of Contents Executive Summary 1 Circulating Tumor Cell (CTC) Diagnostics Market Overview 1.1 Product Overview and Scope of Circulating Tumor Cell (CTC) Diagnostics 1.2 Circulating Tumor Cell (CTC) Diagnostics Segment by Type1.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Growth Rate Comparison by Type (2014-2025) 1.2.2 CTC Enrichment 1.2.3 CTC Detection 1.3 Circulating Tumor Cell (CTC) Diagnostics Segment by Application1.3.1 Circulating Tumor Cell (CTC) Diagnostics Consumption Comparison by Application (2014-2025) 1.3.2 Hospitals and clinics 1.3.3 Pharmaceuticals and biotechnology companies 1.3.4 Academic research institutes 1.3.5 CROs 1.4 Global Circulating Tumor Cell (CTC) Diagnostics Market by Region1.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Circulating Tumor Cell (CTC) Diagnostics Market Size1.5.1 Global Circulating Tumor Cell (CTC) Diagnostics Revenue (2014-2025) 1.5.2 Global Circulating Tumor Cell (CTC) Diagnostics Production (2014-2025) 2 Global Circulating Tumor Cell (CTC) Diagnostics Market Competition by Manufacturers 2.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Market Share by Manufacturers (2014-2019) 2.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Manufacturers (2014-2019) 2.3 Global Circulating Tumor Cell (CTC) Diagnostics Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Circulating Tumor Cell (CTC) Diagnostics Production Sites, Area Served, Product Types 2.5 Circulating Tumor Cell (CTC) Diagnostics Market Competitive Situation and Trends2.5.1 Circulating Tumor Cell (CTC) Diagnostics Market Concentration Rate 2.5.2 Circulating Tumor Cell (CTC) Diagnostics Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Circulating Tumor Cell (CTC) Diagnostics Production Market Share by Regions 3.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Market Share by Regions 3.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Regions (2014-2019) 3.3 Global Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Circulating Tumor Cell (CTC) Diagnostics Production3.4.1 North America Circulating Tumor Cell (CTC) Diagnostics Production Growth Rate (2014-2019) 3.4.2 North America Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Circulating Tumor Cell (CTC) Diagnostics Production3.5.1 Europe Circulating Tumor Cell (CTC) Diagnostics Production Growth Rate (2014-2019) 3.5.2 Europe Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 3.6 China Circulating Tumor Cell (CTC) Diagnostics Production (2014-2019)3.6.1 China Circulating Tumor Cell (CTC) Diagnostics Production Growth Rate (2014-2019) 3.6.2 China Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 3.7 Japan Circulating Tumor Cell (CTC) Diagnostics Production (2014-2019)3.7.1 Japan Circulating Tumor Cell (CTC) Diagnostics Production Growth Rate (2014-2019) 3.7.2 Japan Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 4 Global Circulating Tumor Cell (CTC) Diagnostics Consumption by Regions 4.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption by Regions 4.2 North America Circulating Tumor Cell (CTC) Diagnostics Consumption (2014-2019) 4.3 Europe Circulating Tumor Cell (CTC) Diagnostics Consumption (2014-2019) 4.4 China Circulating Tumor Cell (CTC) Diagnostics Consumption (2014-2019) 4.5 Japan Circulating Tumor Cell (CTC) Diagnostics Consumption (2014-2019) 5 Global Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price Trend by Type 5.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Market Share by Type (2014-2019) 5.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2014-2019) 5.3 Global Circulating Tumor Cell (CTC) Diagnostics Price by Type (2014-2019) 5.4 Global Circulating Tumor Cell (CTC) Diagnostics Production Growth by Type (2014-2019) 6 Global Circulating Tumor Cell (CTC) Diagnostics Market Analysis by Applications 6.1 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Market Share by Application (2014-2019) 6.2 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in Circulating Tumor Cell (CTC) Diagnostics Business 7.1 ApoCell, Inc. (US)7.1.1 ApoCell, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.1.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.1.3 ApoCell, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.1.4 Main Business and Markets Served 7.2 Biocep Ltd. (Israel)7.2.1 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.2.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.2.4 Main Business and Markets Served 7.3 Biocept, Inc. (US)7.3.1 Biocept, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.3.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.3.3 Biocept, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.3.4 Main Business and Markets Served 7.4 Biofluidica Microtechnologies LLC (US)7.4.1 Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.4.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.4.3 Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.4.4 Main Business and Markets Served 7.5 Celltraffix Inc. (US)7.5.1 Celltraffix Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.5.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.5.3 Celltraffix Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.5.4 Main Business and Markets Served 7.6 Clearbridge Biomedics (Singapore)7.6.1 Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.6.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.6.3 Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.6.4 Main Business and Markets Served 7.7 Creatv Microtech, Inc. (US)7.7.1 Creatv Microtech, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.7.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.7.3 Creatv Microtech, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.7.4 Main Business and Markets Served 7.8 Cynvenio Biosystems, Inc. (US)7.8.1 Cynvenio Biosystems, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.8.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.8.3 Cynvenio Biosystems, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.8.4 Main Business and Markets Served 7.9 Epic Biosciences Inc. (US)7.9.1 Epic Biosciences Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.9.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.9.3 Epic Biosciences Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.9.4 Main Business and Markets Served 7.10 Fluxion Biosciences, Inc. (US)7.10.1 Fluxion Biosciences, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production Sites and Area Served 7.10.2 Circulating Tumor Cell (CTC) Diagnostics Product Introduction, Application and Specification 7.10.3 Fluxion Biosciences, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Production, Revenue, Price and Gross Margin (2014-2019) 7.10.4 Main Business and Markets Served 7.11 Ikonisys, Inc. (US) 7.12 IVDiagnostics, Inc. (US) 7.13 Janssen Diagnostics LLC (US) 7.14 QIAGEN Hannover GmbH (Germany) 7.15 RARECELLS SAS (Italy) 7.16 ScreenCell (France) 7.17 STEMCELL Technologies, Inc. (Canada) 8 Circulating Tumor Cell (CTC) Diagnostics Manufacturing Cost Analysis 8.1 Circulating Tumor Cell (CTC) Diagnostics Key Raw Materials Analysis8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Circulating Tumor Cell (CTC) Diagnostics 8.4 Circulating Tumor Cell (CTC) Diagnostics Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.2 Circulating Tumor Cell (CTC) Diagnostics Distributors List 9.3 Circulating Tumor Cell (CTC) Diagnostics Customers 10 Market Dynamics 10.1 Market Trends 10.2 Opportunities 10.3 Market Drivers 10.4 Challenges 10.5 Influence Factors 11 Global Circulating Tumor Cell (CTC) Diagnostics Market Forecast 11.1 Global Circulating Tumor Cell (CTC) Diagnostics Production, Revenue Forecast11.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Production Growth Rate Forecast (2019-2025) 11.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate Forecast (2019-2025) 11.1.3 Global Circulating Tumor Cell (CTC) Diagnostics Price and Trend Forecast (2019-2025) 11.2 Global Circulating Tumor Cell (CTC) Diagnostics Production Forecast by Regions (2019-2025)11.2.1 North America Circulating Tumor Cell (CTC) Diagnostics Production, Revenue Forecast (2019-2025) 11.2.2 Europe Circulating Tumor Cell (CTC) Diagnostics Production, Revenue Forecast (2019-2025) 11.2.3 China Circulating Tumor Cell (CTC) Diagnostics Production, Revenue Forecast (2019-2025) 11.2.4 Japan Circulating Tumor Cell (CTC) Diagnostics Production, Revenue Forecast (2019-2025) 11.3 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Regions (2019-2025)11.3.1 North America Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2019-2025) 11.3.2 Europe Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2019-2025) 11.3.3 China Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2019-2025) 11.3.4 Japan Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast (2019-2025) 11.4 Global Circulating Tumor Cell (CTC) Diagnostics Production, Revenue and Price Forecast by Type (2019-2025) 11.5 Global Circulating Tumor Cell (CTC) Diagnostics Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List
Summary: Get latest Market Research Reports on Circulating Tumor Cell (CTC) Diagnostics . Industry analysis & Market Report on Circulating Tumor Cell (CTC) Diagnostics is a syndicated market report, published as Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2019. It is complete Research Study and Industry Analysis of Circulating Tumor Cell (CTC) Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 28 February, 2019